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COLORECTAL CANCER (CRC)accounts for approximately210 000 deaths each year inEurope.1 The majority of
CRCs arise within adenomatous pol-
yps,2 and polypectomy is associated
with a reduction in CRC incidence and
mortality.3 The target lesions in mass
screening programs are advanced ad-
enomas, which harbor the greatest
cancer risk, and early stage CRC,4 but
adherence to screening procedures re-
mains suboptimal.5,6
Computed tomographic (CT) colo-
nography has been shown to be suffi-
ciently accurate in detecting colorec-
tal neoplasia.7,8 Less invasive and better
tolerated than colonoscopy,9,10 CT colo-
nography is now considered a valid al-
ternative for CRC screening in the gen-
eral population.11
Individuals with first-degree family
history of advanced colorectal neopla-
sia, thosewho have had resection of co-
For editorial comment see p 2498.
Context Computed tomographic (CT) colonography has been recognized as an al-
ternative for colorectal cancer (CRC) screening in average-risk individuals, but less in-
formation is available on its performance in individuals at increased risk of CRC.
Objective To assess the accuracy of CT colonography in detecting advanced colo-
rectal neoplasia in asymptomatic individuals at increased risk of CRC using unblinded
colonoscopy as the reference standard.
Design, Setting, and Participants This was a multicenter, cross-sectional study.
Individuals at increased risk of CRC due to either family history of advanced neoplasia
in first-degree relatives, personal history of colorectal adenomas, or positive results
from fecal occult blood tests (FOBTs) were recruited in 11 Italian centers and 1 Bel-
gian center between December 2004 and May 2007. Each participant underwent CT
colonography followed by colonoscopy on the same day.
Main Outcome Measures Sensitivity and specificity of CT colonography in de-
tecting individuals with advanced neoplasia (ie, advanced adenoma or CRC) 6 mm or
larger.
Results Of 1103 participants, 937 were included in the final analysis: 373 cases in
the family-history group, 343 in the group with personal history of adenomas, and
221 in the FOBT-positive group. Overall, CT colonography identified 151 of 177 par-
ticipants with advanced neoplasia 6 mm or larger (sensitivity, 85.3%; 95% confi-
dence interval [CI], 79.0%-90.0%) and correctly classified results as negative for 667
of 760 participants without such lesions (specificity, 87.8%; 95% CI, 85.2%-90.0%).
The positive and negative predictive values were 61.9% (95%CI, 55.4%-68.0%) and
96.3% (95% CI, 94.6%-97.5%), respectively; after group stratification, a signifi-
cantly lower negative predictive value was found for the FOBT-positive group (84.9%;
95% CI, 76.2%-91.3%; P .001).
Conclusions In a group of persons at increased risk for CRC, CT colonography com-
pared with colonoscopy resulted in a negative predictive value of 96.3% overall. When
limited to FOBT-positive persons, the negative predictive value was 84.9%.
JAMA. 2009;301(23):2453-2461 www.jama.com
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lorectal adenomas, and thosewith posi-
tive results from fecal occult blood tests
(FOBTs) are at increased risk of CRC.
However, adherence to follow-up colo-
noscopy in these individuals is subop-
timal.12-14 Being less invasive and thus
more tolerable, CT colonography may
increase acceptability and adherence to
screening, but little information is avail-
able on its performance.
The aim of our study was to assess
sensitivity and specificity of CT colo-
nography in detecting advanced neo-
plasia (ie, advanced adenoma or CRC)
6 mm or larger in individuals at in-
creased risk of developingCRC, because
of either family history of advanced co-
lorectal neoplasia in first-degree rela-
tives, personal history of adenomas, or
positive results from immunochemi-
cal FOBTs.
METHODS
Study Design and Population
In this multicenter cross-sectional
study, each participant underwent CT
colonography followed by colonos-
copy on the same day. Both tests were
carried out in the same center.
Individuals were eligible for inclu-
sion into the study if they met 1 of 3
categories. Group 1 comprised first-
degree relatives of patients with ad-
vanced colorectal neoplasia diag-
nosed before the age of 60 years and
were aged 40 to 65 years (family-
history group). Group 2 individuals en-
tered a colonoscopy surveillance pro-
gram after endoscopic removal of
colorectal adenomas15 andwere aged 18
to 70 years (postpolypectomy group).
Group 3 comprised individuals with
positive results from FOBTs who were
aged 59 to 69 years and participating
in a CRC screening program (FOBT-
positive group).
Individualswere excluded if they had
any of the following: clinical diagno-
sis of familial adenomatous polyposis
or hereditary nonpolyposis CRC,16 nor-
mal colonoscopy or sigmoidoscopy per-
formed within the last 3 years, diagno-
sis of cancer at any site at the time of
selection, severe comorbidity limiting
life expectancy, inflammatory bowel
disease, celiac disease, autoimmunedis-
ease, symptoms or signs that clinically
warranted colon imaging, evidence of
increased risk of being harmed by un-
dergoing colonoscopy as judged by the
endoscopist, psychological or physi-
cal conditions that contraindicated
colonoscopy, anticoagulant therapy, or
pregnancy at time of study inclusion or
CT colonography.
Center Selection
Participating centers were required to
have the following 4 facilities: a radi-
ology unit equipped with at least one
4-slice CT scanner, where at least 1 ra-
diologist had reported 50 or more CT
colonography procedures under super-
vision of an expert; a digestive endos-
copy unitwith state-of-the-art video en-
doscopy and endoscopists who had
performed at least 500 colonoscopies
and 100 polypectomies; a general sur-
gery unit; and a pathology unit with a
pathologist experienced in evaluating
colorectal diseases. The centers also
needed the resources to perform at least
50 extra CT colonography procedures
and 50 extra colonoscopies yearly in ad-
dition to their routine workloads. Fol-
lowing a start-up visit by investigators
from the coordinating center, 21 cen-
ters (20 in Italy, 1 in Belgium)were ap-
proved to join the study; each center
was required to enroll at least 1 par-
ticipant permonth. An institutional re-
view board including all participating
centers agreed on the study protocol,
which was then approved by each cen-
ter’s ethical committee.
Participant Enrollment
Eligible participants were prospec-
tively selected in each center by a study
investigator in 3 ways. Relatives of pa-
tients with advanced neoplasia were re-
cruited into the family-history group
(group 1) after interviews with all pa-
tients referred for surgery or endo-
scopic polypectomy because of histo-
logically proven advanced colorectal
neoplasia diagnosed before the age of
60 years; their first-degree relatives aged
40 to 65 years were identified and per-
mission obtained to contact them. Par-
ticipants were identified for groups 2
and 3 by interviewing all individuals
without personal history of colorectal
neoplasia who attended the gastroen-
terology units involved in the study and
by periodically checking indications for
colonoscopy reported in the endos-
copy waiting list.
All eligible participants were con-
tacted, interviewed, and offered par-
ticipation in the study. Individuals who
accepted were prospectively regis-
tered and booked for same-day and
same-centerCTcolonography and colo-
noscopy.Written informed consentwas
obtained from each participant. A dedi-
cated password-protected databasewas
designed and managed on a secure
server by the Clinical Trials Core Fa-
cility of the National Institute for Can-
cer Research, Genoa, Italy (http:
//clinicaltrials.istge.it/ist/rde).
CT Colonography Protocol
Full bowel purgation was required be-
cause participants had to undergo colo-
noscopy on the same day as CT colo-
nography. No specific colon cleansing
directions were given to the participat-
ing centers, but internationally recog-
nized quality standards had to bemet.17
Hydrosoluble iodine agents alone or in
combination with barium sulfate were
accepted for oral tagging.7,18
Each participant was placed on a CT
table and a small flexible rectal cath-
eter was positioned. N-butyl-scopola-
minewas administered intravenously ac-
cording to common practice in the
participating centers. Immediately be-
fore scanning, pneumocolon was ob-
tained through insufflation of room air
or carbon dioxide; this was performed
either manually using a balloon pump
orwith an automatic device until maxi-
mum tolerance was reached. Com-
puted tomographic colonography was
performedwith theparticipant in the su-
pine and prone positions with the fol-
lowing scanning protocol: 120 kilovolt
peak (kVp), 50or fewer effectivemAper
second, and a section thickness not
greater than 2.5 mm. Intravenous con-
trastmediumwasnot administered.Du-
ration of CT colonography, reporting
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time, and adverse events were re-
corded.
On completion of the CT scan, 1 ra-
diologist interpreted the CT colonogra-
phyonhis or her ownworkstationusing
either 2-dimensional or 3-dimensional
primary reading according to prefer-
ence. Lesions were assigned to 1 of the
following bowel segments: cecum, as-
cending colon including thehepatic flex-
ure, transverse colon including the
splenic flexure, descending colon, sig-
moid colon, and rectum.Lesion sizewas
reported as themeasurement of its larg-
est diameter (the stalk of thepolypwhen
visible was not considered formeasure-
ment) on2-dimensional reformatted im-
ages, using a standard window setting
of 1500Hounsfield units. The results of
theCTcolonography interpretationwere
recordedondifferent pages, one for each
of the 6 bowel segments, and put sepa-
rately into sealed envelopes thatwerede-
livered to the endoscopy unit where
colonoscopywas scheduled. Because of
the low specificity of CT colonography
for small lesions, polyps smaller than 6
mmwere recorded but not registered in
the envelopes delivered to the endos-
copy unit.19
Colonoscopy Protocol
Colonoscopy was performed at least 3
hours after CT colonography. Seda-
tion was carried out according to the
common clinical practice of each par-
ticipating center.
The endoscope was advanced to the
cecum and the entire length of the
bowel was examined during endo-
scopewithdrawal. The endoscopist was
initially blinded to the result ofCT colo-
nography; at the end of each bowel seg-
ment evaluation, CT colonography re-
sults for that segment were disclosed
(segmental unblinding). If a polypmea-
suring 6 mm or larger was detected at
CT colonography but not at colonos-
copy, the segment was reexamined to
resolve the discrepancy.20 The dura-
tion of colonoscopy and any adverse
events were recorded.
Radiologists and endoscopists were
required to evaluate the adequacy of
preparation for each segment of the
bowel. Global examination quality was
considered optimal when distension
and visualization of the bowelwall were
excellent; good when part of the bowel
wall was not visualized due to luminal
collapse, fluid, or stool (however, still
allowing detection of lesions10mm);
and poor when examination quality
could not guarantee visualization of
large lesions.21 Themain reasons for in-
complete visualization (fecal and/or liq-
uid residue or collapsed segment) were
recorded.
Lesion Matching and Classification
According to the adopted segmental
checking procedure, a lesion found at
CT colonographywasmatched to a cor-
responding one found at colonoscopy
when it was located in the same or ad-
jacent colon segment and when its size
differed by nomore than 50%.7 Match-
ing was performed immediately after
conclusion of both tests, if necessary by
reviewing colonoscopy video registra-
tion andCT colonography images. This
algorithm was used only for the “per-
polyp” analysis.
Lesion size was measured at endos-
copy using open biopsy forceps. All vis-
ible lesions were removed; those re-
trieved were sent for local pathologist
evaluation and classified according to
criteria from the World Health Orga-
nization.22 Adenomas were consid-
ered advanced when 10 mm or larger,
if they had a 20% ormore villous com-
ponent, or if they had high-grade dys-
plasia; all the others were considered
low-risk adenomas.
Statistical Methods
The reference standard for lesion diag-
nosis was the result of the unblinded
colonoscopy (ie, all polyps6mmde-
tected at colonoscopy before and after
segmental unblinding of CT colonog-
raphy) and the histological evaluation
of the removed polyps. Reasons for ex-
clusion from the analyses were indi-
cated in the research protocol as fol-
lows: cases entered by a center that
enrolled fewer than 1 participant per
month during the study period, par-
ticipants who withdrew their consent
before testing or refused to undergoCT
colonography or colonoscopy, incom-
plete colonoscopy with a negative test
result up to the examined point, or his-
tology of the largest lesion not being
available. Participants with a com-
plete CT colonography and a diag-
nostic colonoscopy, including those
interrupted due to obstruction, were
considered for analysis.
End Points. The primary end point
of the study was CT colonography per-
formance as a screening test using un-
blinded colonoscopy as the reference
standard. The analysis was performed
according to a per-patient evaluation.
Participants were considered as hav-
ing a positive result at the reference
standardwhen at least 1 advanced neo-
plasia 6 mm or larger was found at the
reference standard.When 2 ormore le-
sions were removed in the same pa-
tient, the one with the worst histology
was classified as the index lesion; for
multiple lesions with the same histol-
ogy, the largest onewas considered. Par-
ticipants without colorectal lesions,
those with nonadenomatous lesions,
thosewithnonadvanced adenomas, and
those with advanced adenomas smaller
than 6 mm were classified as having
negative results.
Computed tomographic colonogra-
phy was reported to be positive when
at least 1 lesion 6mm or larger was de-
tected; otherwise, it was reported as
negative. If CT colonographywas posi-
tive and the index lesion was an ad-
vanced neoplasia 6 mm or larger, the
CT colonography result was consid-
ered to a true positive. If CT colonog-
raphywas positive but the casewas clas-
sified as negative at the reference
standard, the CT colonography result
was considered a false positive. Com-
puted tomographic colonography sen-
sitivity, specificity, positive predictive
value, and negative predictive value,
along with their relative 95% confi-
dence intervals (CIs), were calculated
cumulatively and according to study
group.
Secondary End Points. Per-patient
sensitivity, specificity, and positive and
negative predictive values were calcu-
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lated also for advancedneoplasia 10mm
or larger. For this purpose, if the CT
colonography result was positive and
the index lesion was an advanced neo-
plasia 10 mm or larger, the CT colo-
nography result was considered a true
positive for a lesion in that size class.
If the CT colonography result was posi-
tive but no advanced neoplasia 10 mm
or larger was found at unblinded colo-
noscopy, the CT colonography result
was considered a false positive for a
lesion in that size range. Per-polyp sen-
sitivitywas calculated as the percentage
of positive CT colonography match-
ing findings among all advanced neo-
plasia sized in the range of interest that
were detected at unblinded colonos-
copy, using thematching algorithm de-
scribed before.
The 2 test was used to assess statis-
tical significance of differences among
proportions. All P values involved hy-
pothesis tests against a 2-sided alter-
native and were considered significant
when P .05. The analyses were per-
formed using SAS release 9.1 (SAS In-
stitute, Cary, North Carolina).
Sample Size Estimate.We assumed
that CT colonography could be pro-
Figure. Flow Diagram of Observational Cohort for Study of Diagnostic Accuracy of CT Colonography in Individuals at Increased Risk
of Colorectal Cancer
453 FH group
1103 Participants enrolled
374 PP group
276 FOBT group
398 FH group
982 Underwent CT colonography
352 PP group
232 FOBT group
351 FH group
731 Had negative results on CT
colonography
272 PP group
108 FOBT group
47 FH group
251 Had positive results on CT
colonography
80 PP group
124 FOBT group
349 FH group
726 Underwent colonoscopy
assessment
272 PP group
105 FOBT group
46 FH group
247 Underwent colonoscopy
assessment
77 PP group
124 FOBT group
33 Excluded
32 Cecum not reached
20 FH group
6 PP group
6 FOBT group
1 Histology of largest lesion
not available (FH group)
3 Excluded
1 Cecum not reached (FH group)
2 Histology of largest lesion
not available (FOBT group)
5 FH group
26 Had advanced
neoplasia ≥6 mm
6 PP group
15 FOBT group
323 FH group
667 Did not have advanced
 neoplasia ≥6 mm
260 PP group
84 FOBT group
23 FH group
151 Had advanced
neoplasia ≥6 mm
32 PP group
96 FOBT group
22 FH group
93 Did not have advanced
neoplasia ≥6 mm
45 PP group
26 FOBT group
121 Excluded
37 Enrolled at centers that recruited
<1 participant per month
16 FH group
5 PP group
16 FOBT group
84 Dropped out
39 FH group
17 PP group
28 FOBT group
1 FH group
4 Excluded (no colonoscopy
assessment)
3 PP group
2 FH group
5 Excluded (no colonoscopy
assessment)
3 FOBT group
CT indicates computed tomographic; FH, family history; PP, postpolypectomy; FOBT, fecal occult blood test–positive.
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posed as a screening test if its sensitiv-
ity was 70% or greater. Assuming that
150 participants had advanced lesions
found at colonoscopy, the precision of
the estimates would be approximately
±7% forCTcolonography sensitivity be-
tween 80% and 90%. Thus, under a
conservative assumption that CT colo-
nography sensitivity for advanced le-
sions was greater than 80%, the study
had greater than 90% power of reject-
ing the hypothesis at .05 (1-sided level
of significance) that CT colonography
true sensitivity was 70% or less. The
projected prevalence of advanced le-
sions in the study population ranged
from 4% to 15% depending on the rela-
tive contribution of the 3 study groups.
Accordingly, it was estimated that no
fewer than 1000 participants would
have had to be enrolled for the study
to have sufficient statistical power and
that recruitment had to be continued
until 150 participants with advanced
neoplasia had been found at un-
blinded colonoscopy.
RESULTS
BetweenDecember 2004 andMay2007,
1103 participants were enrolled in 17
centers. Recruitment varied between 1
and 291 participants per center. Of the
enrolled participants, 937 participants
(85.0%) from 12 centers (11 in Italy, 1
in Belgium)were included in the analy-
sis (FIGURE). Of those 937 partici-
pants, 373 (39.8%) were in the family-
history group, 343 (36.6%) in the
postpolypectomy group, and 221
(23.6%) in the FOBT-positive group;
the prevalence of advanced neoplasia
was 7.5%, 11.1%, and 50.2%, respec-
tively (P .001). Participant charac-
teristics and size and histology of the
colorectal findings are reported in
TABLE 1.
Technical details of the CT colonog-
raphy examination are in TABLE 2.
There were no clinically significant
complications after CT colonography.
The median time spent by partici-
pants in the CT suite (available for 658
participants) was 15 minutes (range,
10-50 minutes). The median time re-
quired for interpretation of theCT colo-
nography studies was 18 minutes
(range, 3-55 minutes); time spent was
shorter for primary 2-dimensional as-
sessment (17minutes; range, 3-55min-
utes) than for primary 3-dimensional
assessment (20 minutes; range, 5-55
minutes; P .001).
Global examination quality was re-
ported for 863 participants. It was op-
timal in 533 participants (61.8%), good
in 282 (32.7%), and poor in 48 (5.6%).
The main reasons for poor-quality ex-
aminationswere fecal residue in 33 par-
ticipants (3.8%), liquid residue in 5
(0.6%), and bowel collapse in 5 (0.6%);
the reason for poor global examina-
tion quality was not recorded in 5 cases
(0.6%).
The CT colonography sensitivity,
specificity, and positive and negative
predictive values to detect a partici-
pant with at least 1 advanced neopla-
sia 6mmor largerwere 85.3% (95%CI,
Table 1. Demographic Characteristics and Colorectal Findings of the Study Participants
All
(N = 937)
Study Group
Family-History
(n = 373)
Postpolypectomy
(n = 343)
FOBT-Positive
(n = 221)
Age at enrollment, median (range), y 60.0 (30-70) 51.1 (40-65) 61.0 (30-70) 65.0 (59-70)
Sex, No. (%)
Female 422 (45.0) 198 (53.1) 133 (38.8) 91 (41.2)
Male 515 (55.0) 175 (46.9) 210 (61.2) 130 (58.8)
Colorectal findings, No. (%)
Negative for advanced neoplasia 6 mm 760 (81.1) 345 (92.5) 305 (88.9) 110 (49.8)
No lesion 521 (55.6) 259 (69.4) 207 (60.3) 55 (24.9)
Any histology 6 mm 184 (19.6) 71 (19.0) 69 (20.1) 44 (19.9)
Nonadenomatous lesiona 27 (2.9) 11 (3.0) 13 (3.8) 3 (1.4)
Low-risk adenoma 28 (3.0) 4 (1.1) 16 (4.7) 8 (3.6)
Positive for advanced neoplasia 6 mm 177 (18.9) 28 (7.5) 38 (11.1) 111 (50.2)
Advanced adenoma 6-9 mm 43 (4.6) 9 (2.4) 8 (2.3) 26 (11.8)
Advanced adenoma 10 mm 93 (9.9) 15 (4.0) 25 (7.3) 53 (24.0)
Carcinoma 6-9 mm 3 (0.3) 0 0 3 (1.4)
Carcinoma 10 mm 38 (4.1) 4 (1.1) 5 (1.5) 29 (13.1)
Abbreviation: FOBT, fecal occult blood test.
a In 27 cases, the index lesion was nonadenomatous: in 19, 1, and 7 cases, this was a hyperplastic polyp sized 6-9 mm, a hyperplastic polyp sized 10 mm, and normal colonic
mucosa or other benign lesions 6 mm, respectively.
Table 2. Technical Details of the Computed
Tomographic Colonography Examinations
Total,
No. (%)
(N = 937)
Fecal tagging
Not administered 620 (66.2)
Administered 317 (33.8)
Computed tomographic scanner
4-8 rows 109 (11.6)
16 rows 658 (70.3)
32-64 rows 170 (18.1)
Reconstruction interval
0.6-1.0 mm 404 (43.1)
1.2-1.5 mm 533 (56.9)
Slice thickness
1.00-1.25 mm 475 (50.7)
2.0-2.5 mm 462 (49.3)
Type of primary assessment
2-Dimensional 697 (74.4)
3-Dimensional 240 (25.6)
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79.0%-90.0%), 87.8% (95%CI, 85.2%-
90.0%), 61.9% (95% CI, 55.4%-
68.0%), and 96.3% (95% CI, 94.6%-
97.5%), respectively.
Consideringonlydisease-positivepar-
ticipants with advanced neoplasia 10
mm or larger, CT colonography identi-
fied 119 of 131 participantswith at least
1 such lesion (sensitivity, 90.8%; 95%
CI, 84.2%-95.0%) and 681 of 806 par-
ticipants without (specificity, 84.5%;
95%CI, 81.8%-86.9%); the correspond-
ing positive and negative predictive
values were 48.8% (95% CI, 42.3%-
55.2%) and 98.3% (95% CI, 97.0%-
99.1%), respectively. Sensitivity for par-
ticipants with cancer was 95.1% (95%
CI, 83.5%-99.4%);CTcolonographyde-
tected 39 of 41 participants with can-
cer, including all 3 with diameters of 6
to 9 mm. The diagnostic performance
of CT colonography in detecting par-
ticipants with at least 1 advanced neo-
plasia 6 mm or larger according to the
risk group is in TABLE 3. When com-
paringCTcolonographyperformance in
the 3 different groups of participants,
sensitivity for advanced neoplasia 6mm
or largerwas similar.On the other hand,
specificitywas significantly higher in the
family-history and postpolypectomy
groups as compared with the FOBT-
positive group (93.6% and 85.3% vs
76.4%, respectively; P .001).
Positive predictive value varied be-
tween 41.6% in the postpolypectomy
group and 78.7% in the FOBT-positive
group (P .001), and the negative pre-
dictive value ranged between 84.9% in
the FOBT-positive group and 98.5% in
the family-history group (P .001). The
test-positive rate in the family-history,
postpolypectomy, and FOBT-positive
groups was 12.1%, 22.4%, and 55.2%,
respectively.
TABLE 4 lists results of the retrospec-
tive analysis performed by 2 experi-
enced radiologists on the 93 cases that
were negative at colonoscopy and clas-
sified as positive at CT colonography.
The false-positive rate varied from6.4%
in the family-history group to 23.6% in
theFOBT-positive group. Themain rea-
sons for erroneous CT interpretation
were presence of nonadvanced neopla-
sia in polyps 6 mm or larger (n=42;
5.5%) and perception errors (n=17;
2.2%).
A total of 375 lesions 6mm or larger
were detected in 235 participants. His-
tology and size of the 347 endoscopi-
cally retrieved lesions are reported in
TABLE 5 according to their bowel lo-
cation. Sensitivity according to the per-
polyp analysis is listed in TABLE 6.
Blinded colonoscopy missed 2 ad-
vanced adenomas: a 13-mm peduncu-
lated polyp in the cecum and an 18-mm
flat lesion in the ascending colon. Two
participantswere hospitalized for bleed-
ing after polypectomy.
COMMENT
The overall per-patient sensitivity for
CT colonography detecting advanced
neoplasia 6 mm or larger and 10 mm
or larger was 85.3% and 90.8%, respec-
tively, which are comparable with fig-
ures reported in 2 large trials on aver-
age-risk individuals7,8 but higher than
Table 4. Analysis of False-Positive Results From Computed Tomographic Colonography
Reason for
False-Positive
Classification
No. (%)
All
(760
Negative
Cases)
Study Group
Family-History
(345 Negative
Cases)
Postpolypectomy
(305 Negative
Cases)
FOBT-Positive
(110 Negative
Cases)
Polyp 6 mma 42 (5.5) 11 (3.2) 20 (6.6) 11 (10.0)
Polyp 4-5 mmb 10 (1.3) 2 (0.6) 4 (1.3) 4 (4.0)
Perception errorc 17 (2.2) 4 (1.2) 5 (1.6) 8 (7.0)
Fecal residue 16 (2.1) 2 (0.6) 11 (3.6) 3 (3.0)
Spasm 2 (0.3) 0 2 (0.7) 0
Appendiceal stump 1 (0.1) 0 1 (0.3) 0
Fold 3 (0.4) 2 (0.6) 1 (0.3) 0
CT colonography image
not available
2 (0.3) 1 (0.3) 1 (0.3) 0
Total 93 (12.2) 22 (6.4) 45 (14.8) 26 (23.6)
Abbreviations: CT, computed tomographic; FOBT, fecal occult blood test.
aNonadenomatous lesion or low-risk adenoma with size 6 mm at endoscopic assessment.
bLesion of any histology sized 4-5 mm at endoscopic assessment with a diameter 6 mm at CT colonography.
cFinding that was not confirmed by retrospective review.
Table 3. Per-Patient Analysis of Computed Tomographic Colonography in Detecting Advanced Neoplasia
Performance Measure All
Study Group
Family-History Postpolypectomy FOBT-Positive P Valuea
Sensitivity, % (95% CI) 85.3 (79.0-90.0) 82.1 (62.4-93.2) 84.2 (68.1-93.4) 86.5 (78.4-92.0)
.58
No. of patients 177 28 38 111
Specificity, % (95% CI) 87.8 (85.2-90.0) 93.6 (90.4-95.9) 85.3 (80.7-88.9) 76.4 (67.1-83.7)
.001
No. of patients 760 345 305 110
Positive predictive value, % (95% CI) 61.9 (55.4-68.0) 51.1 (36.0-66.1) 41.6 (30.6-53.3) 78.7 (70.2-85.4)
.001
No. of patients 244 45 77 122
Negative predictive value, % (95% CI) 96.3 (94.6-97.5) 98.5 (96.5-99.5) 97.7 (95.2-99.2) 84.9 (76.2-91.3)
.001
No. of patients 693 328 266 99
Abbreviations: CI, confidence interval; FOBT, fecal occult blood test.
aAccording to the 2 test for differences among the 3 groups.
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those of 2 previous multicenter stud-
ies that included patients with clinical
indication for colonoscopy or those
with family history of CRC.23,24 Com-
puted tomographic colonography can
only classify a lesion by its size. Thus,
large hyperplastic polyps or large low-
risk adenomas can generate false-
positive findings on CT colonography
when considering as positive only pa-
tients with advanced neoplasia 6 mm
or larger, as we did in our study. This
may lead to a possible reduction of CT
colonography specificity. In our sur-
vey, the index lesionwas a low-risk ad-
enoma or a nonadenomatous lesion in
28 and 27 participants, respectively,
thus accounting for only 5.9% of the
participants. Therefore, our specific-
ity was similar to that of other studies
primarily aimed at detecting adeno-
mas 6 mm or larger independently of
their histology.7,8
Computed tomographic colonogra-
phy was performed safely: no serious
adverse events were recorded. Further-
more, to minimize radiation-induced
cancer risk, we adopted a low-dose pro-
tocol that did not negatively affect CT
colonographyperformance.25Our study
also provided the opportunity to as-
sess CT colonography performance in
3 different groups of asymptomatic in-
dividuals at increased risk of carrying
advanced colorectal neoplasia. This al-
lowed us to draw important practical
implications.
The prevalence of advanced neopla-
sia in our participants with family his-
tory of advanced colorectal neoplasia
was 7.5%, which is similar to the fig-
ures reported elsewhere.12,26 Our val-
ues of a 12% test-positive rate, 51%
positive predictive value, and 82% sen-
sitivity suggest a potentially effective use
of CT colonography as an alternative
to colonoscopy for screening individu-
als with family history of advanced co-
lorectal neoplasia. Computed tomo-
graphic colonography has been shown
to be better accepted than colonos-
copy27 and has a negligible risk of se-
rious adverse events; thus, it may help
increase the low adherence reported for
individuals who are candidates for
Table 5. Histology and Size of Lesions Detected on Reference Standard According to Location
Segment and Histological Type
Size
Total (n = 347)6-9 mm (n = 173) 10 mm (n = 174)
Rectum
Carcinoma 1 4 5
Advanced adenoma 14 20 34
Low-risk adenoma 7 0 7
Nonadenomatous lesion 9 1 10
Sigmoid colon
Carcinoma 1 14 15
Advanced adenoma 18 51 69
Low-risk adenoma 23 0 23
Nonadenomatous lesion 10 6 16
Descending colon
Carcinoma 0 5 5
Advanced adenoma 6 13 19
Low-risk adenoma 9 0 9
Nonadenomatous lesion 1 1 2
Transverse colon
Carcinoma 0 7 7
Advanced adenoma 7 13 20
Low-risk adenoma 10 0 10
Nonadenomatous lesion 9 2 11
Ascending colon
Carcinoma 1 8 9
Advanced adenoma 15 14 29
Low-risk adenoma 6 0 6
Nonadenomatous lesion 8 1 9
Cecum
Carcinoma 0 3 3
Advanced adenoma 7 11 18
Low-risk adenoma 6 0 6
Nonadenomatous lesion 5 0 5
Total
Carcinoma 3 41 44
Advanced adenoma 67 122 189
Low-risk adenoma 61 0 61
Nonadenomatous lesion 42 11 53
Table 6. Per-Polyp Analysis of the Sensitivity of CT Colonography for the Detection of Advanced
Adenoma and Cancera
Size
6 mm 10 mm 6-9 mm
Advanced adenoma
Sensitivity, % (95% CI) 72.0 (65.0-78.2) 80.3 (72.2-87.0) 56.7 (44.0-68.8)
Detected lesions 136 98 38
No. of lesions 189 122 67
Carcinoma
Sensitivity, % (95% CI) 95.5 (84.5-99.4) 95.1 (83.5-99.4) 100 (36.8-100)
Detected lesions 42b 39b 3
No. of lesions 44 41 3
All advanced lesions
Sensitivity, % (95% CI) 76.4 (70.3-81.6) 84.1 (77.3-89.1) 58.6 (46.2-70.0)
Detected lesions 178 137 41
No. of lesions 233 163 70
Abbreviations: CI, confidence interval, CT, computed tomographic.
aSensitivity for each size class was calculated as the proportion of matching lesions detected at CT colonography
among those detected by the reference standard (see “Methods” for matching algorithm). Lesion size was deter-
mined according to the reference standard (comparison with open forceps).
bCTcolonographymissed2carcinomas: a30-mmprotrudingmass in thesigmoidanda20-mmsessile lesion in thececum.
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screening,12 which is the main nega-
tive factor affecting its efficacy in re-
ducing mortality from CRC.
Surveillance colonoscopy following
polypectomy accounts for approxi-
mately one-fourth of all endoscopic pro-
cedures,28 but the yield in terms of pol-
ypectomy rate is very low despite this
workload. In our postpolypectomy
group, the prevalence of advanced neo-
plasia was 11%, in line with the avail-
able literature.29 Lower figures are ob-
served in patients without high-risk
adenomas at the index colonoscopy, but
our protocol did not stratify partici-
pants according to this information. Ac-
cording to our results, 16% of ad-
vanced adenomas developing during
postpolypectomy follow-upwould have
not been detected by CT colonogra-
phy.However, this negative aspectmust
be weighed against the higher drop-
out rate reported during colonoscopy
follow-up of postpolypectomy pa-
tients.13 Here again, the better accep-
tance27 and lower invasiveness of CT
colonography might reduce this drop-
out rate, thusmaking it an effective test
for increasing in absolute terms the pro-
tective effect of postpolypectomy fol-
low-up toward the development of
CRC. This strategy may be most use-
ful in patients whose index lesion is a
low-risk adenoma, thus reducing the
workload of endoscopy units while still
ensuring an efficient detection rate of
clinically relevant lesions.
The prevalence of advanced colorec-
tal neoplasia in our participants with
positive FOBT results was 50%, which
is also in line with the reported litera-
ture.30 Despite this evidence, nonad-
herence to post-FOBT colonoscopy has
been shown to occur in up to one-
third of cases.14 This would obviously
reduce the efficacy of mass screening
using FOBT. Our results do not sup-
port using CT colonography as a first-
line strategy in FOBT-positive sub-
jects. Because of the high prevalence
of advanced neoplasia in this group of
participants, colonoscopy would have
been performed in 55% of the cases if
CT colonography had been used as a
screening test, making such a strategy
not as cost-effective as using colon-
oscopy as a first-line screening test. This
statement is also supported by the
low specificity (76%) in our FOBT-
positive participants, because of the
higher rate of nonadenomatous le-
sions and low-risk adenomas detected
at CT colonography and the high rate
of observer errors in this group. Er-
rors may be explained by radiologists
not being blinded to the participant’s
group; the awareness of an expected
high prevalence of disease in FOBT-
positive participants might increase
false-positive reporting, thus generat-
inguseless referral to colonoscopy.Nev-
ertheless, the high accuracy of CT colo-
nography for cancer in our study is a
valid argument for its use in FOBT-
positive patients who refuse colonos-
copy.
Therewere 3 limitations to the study.
The first limitation is that, because this
was a multicenter study, CT colonog-
raphy protocols and radiologist expe-
rience were probably not uniform
across participating centers; it has not
been assessed how results could have
been affected by differences in colon
preparation, scanning protocol, and in-
terpretation paradigm. However, this
study was designed while bearing in
mind how CT colonography is typi-
cally performed in daily clinical prac-
tice. To further improve test perfor-
mance, CT colonography technique
should be standardized internation-
ally and adequate training strategies
implemented.
A second limitation of our studywas
the variable working conditions be-
tween centers and the variable motiva-
tions of the radiologist, and this limi-
tation may have adversely affected CT
colonography performance. Most ra-
diology units have heavy clinical work-
loads, and our protocol imposed on the
radiologist a 3-hour time limit for re-
porting CT colonography results to the
endoscopy suitewhile still handling on-
going routine clinical work. Both of
these stress factors create nonideal con-
ditions in a screening setting. Further-
more, the time it took to interpret CT
colonography results was lengthy and
might not be cost-effective in mass
screening programs. Also, the prior
knowledge that their reports would be
checked against those of the subse-
quent colonoscopy findingsmight have
caused radiologists to take more time
in an effort to be more accurate. Com-
puter-aided diagnosis and reporting in
a protected environmentmight help in-
crease accuracy of CT colonography
screening and reduce reporting time. A
third limitation is that colonoscopywas
used as the reference standard; colo-
noscopy itself may miss some lesions
and longer-term follow-up is needed to
determine whether clinically signifi-
cant lesions were missed.
In summary, in a group of persons
at increased risk of CRC, CT colonog-
raphy compared with colonoscopy re-
sulted in a negative predictive value of
96.3% and a positive predictive value
of 61.9% overall. When limited to
FOBT-positive persons, the negative
predictive value was 84.9%.
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